西藏药业：公司目前没有明确治疗流感病毒的药

Core Viewpoint - The company currently does not have a specific drug for treating influenza virus, but it offers a product called Xiaoer Shuangqing Granules, which is a national Class III new drug and a Category B product under the national medical insurance system [1] Company Summary - Xiaoer Shuangqing Granules is exclusively produced and sold by the company [1] - The product is recommended in the "Clinical Application Guidelines for Traditional Chinese Medicine in Treating Acute Upper Respiratory Infections in Children - 2020" [1] - The main functions of the product include clearing heat and detoxifying, addressing both exterior and interior conditions [1] Indication Summary - The product is indicated for children with symptoms of exterior heat syndrome, including fever, runny nose, red throat, thirst, dry stools, red urine, red tongue, and yellow coating [1] - It is specifically used for acute upper respiratory infections presenting with the aforementioned symptoms [1]